Cytochrome P-450 CYP2B6 Inhibitors (moderate)
- Name
- Cytochrome P-450 CYP2B6 Inhibitors (moderate)
- Accession Number
- DBCAT002621
- Description
Not Available
- Drugs
Drug Drug Description Clopidogrel An antiplatelet agent used to prevent blood clots in peripheral vascular disease, coronary artery disease, and cerebrovascular disease. Thiotepa An alkylating agent used to prevent graft rejection in stem cell transplantation and to treat a variety of malignancies including certain types of adenocarcinoma and superficial bladder carcinomas. Curcumin No approved therapeutic indications. Sorafenib A kinase inhibitor used to treat unresectable liver carcinoma, advanced renal carcinoma, and differentiated thyroid carcinoma. Tamoxifen A selective estrogen receptor modulator used to treat estrogen receptor positive breast cancer, reduce the risk of invasive breast cancer following surgery, or reduce the risk of breast cancer in high risk women. Ketoconazole A broad spectrum antifungal used to treat seborrheic dermatitis and fungal skin infections. Ticlopidine A platelet aggregation inhibitor used in the prevention of conditions associated with thrombi, such as stroke and transient ischemic attacks (TIA). Voriconazole A triazole compound used to treat fungal infections. - Drugs & Drug Targets